Price
No data yet.
Social Signal Score
Analyst Ratings
3 analystsRevenue
$684.11M+53.72%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Luis E. Rojo
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 2,328
- Beta
- 0.95
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 2.57
Financials
Revenue
$684.11M+53.7%Net Income
$22.91M+7.3%EBITDA
$69.15M+45.6%Free Cash Flow
$-29.00M-319.9%EPS (diluted)
$1.00+8.7%Shares Outstanding (diluted)
22.89M-1.1%Operating Expenses
$56.26MCash & Debt
$113.70MReturn of Capital
$17.94MRevenue by Segment (annual)
$2.33BDividend per Share
$0.40Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.33B | $46.90M | $2.05 |
| 2024 | $2.18B | $50.37M | $2.21 |
| 2023 | $2.33B | $40.20M | $1.77 |
| 2022 | $2.77B | $147.15M | $6.46 |
| 2021 | $2.35B | $137.80M | $6.01 |
| 2020 | $1.87B | $126.77M | $5.52 |
| 2019 | $1.86B | $103.13M | $4.47 |
| 2018 | $1.99B | $112.76M | $4.90 |
| 2017 | $1.93B | $91.58M | $4.39 |
| 2016 | $1.77B | $86.19M | $3.78 |
| 2015 | $1.78B | $75.97M | $3.34 |
| 2014 | $1.93B | $57.10M | $2.51 |
| 2013 | $1.88B | $72.83M | $3.22 |
| 2012 | $1.80B | $79.40M | $3.71 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from SCL's reported EPS growth of -4.5% a year over 13 years.
- EPS in 5 years
- $1.63
- Implied price
- $37.46
- Return from $61.87
- -9.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $18.62 — -69.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 17 | 20 | 23 | 26 | 29 |
|---|---|---|---|---|---|
| -14.5% | -23.8% | -21.3% | -19.0% | -17.0% | -15.2% |
| -9.5% | -19.3% | -16.6% | -14.3% | -12.2% | -10.2% |
| -4.5% | -14.9% | -12.0% | -9.5% | -7.3% | -5.3% |
| 0.5% | -10.4% | -7.4% | -4.8% | -2.4% | -0.3% |
| 5.5% | -5.9% | -2.8% | -0.1% | 2.4% | 4.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100-4.76%Social Signal Score
Mentions (4)
- Newsprnewswire.com·10d ago·Neutral
Stepan to Announce Third Quarter 2026 Results on October 28, 2026 NORTHBROOK, Ill., Oct. 7, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its third quarter 2026 earnings results on Wednesday, October 28, 2026 at approximately 7:00 a.m.
View source ↗ - Newsseekingalpha.com·18d ago·Positive
Stepan Company: The Cost Savings Are Doing Real Work Stepan Company is regaining momentum, with strong margin recovery and robust volume and pricing growth across core segments. SCL's pass-through mechanisms and Project Catalyst cost savings are driving significant EBIT and net income improvements despite volatile feedstock costs. North American sales, particularly in surfactants and polymers for data center construction, are outpacing global growth and expanding SCL's market share.
View source ↗ - Newsdefenseworld.net·45d ago·Neutral
Stepan (NYSE:SCL) versus Tronox (NYSE:TROX) Critical Contrast Tronox (NYSE: TROX - Get Free Report) and Stepan (NYSE: SCL - Get Free Report) are both small-cap materials companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of current recommendations
View source ↗ - Newsmarketbeat.com·50d ago·Neutral
Stepan Eyes Margin Recovery as Catalyst Targets $100M in Savings Stepan NYSE: SCL is in the early stages of a margin recovery, supported by growth in higher-margin product areas, cost reductions and broader-based volume gains, Chief Financial Officer Ruben Velasquez said during a company presentation.
View source ↗
Earnings
Wed, Oct 28(in 11 days)
Consensus estimate $0.72 per share
Typical surprise +16.9% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$1.18 vs $0.61beat
- Tue, Apr 28$0.45 vs $0.39beat
- Mon, Feb 23$-0.02 vs $0.35miss
- Wed, Oct 29$0.48 vs $0.36beat
- Wed, Jul 30$0.52 vs $0.92miss
- Tue, Apr 29$0.84 vs $0.51beat
Estimates and results for SCL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SCL officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SCL.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.